News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
Making it count – the real life stories of people benefiting from innovative new cancer treatments
We are in an exciting time in cancer research, with many researchers believing we are at the tipping point in cancer treatment, and moving towards truly personalised treatment plans for patients.
New cancer drugs taking longer to reach NHS patients
NHS patients are waiting longer for new cancer drugs because of delays in taking them through clinical trials and getting them approved for use, a major new analysis of regulatory data reveals.
Scientific achievements of 2018
We've selected a range of discoveries from 2017/18 – chosen because they illustrate the quality and breadth of our basic, translational and clinical research and our ambitions under the ICR's research strategy.
Immunotherapy keeps some patients with advanced head and neck cancer alive for more than three years
A new immunotherapy can greatly extend the lives of a proportion of people with advanced head and neck cancer, with some living for three years or more, a major new clinical trial reports.
Gene test predicts likelihood of stomach or oesophageal cancer relapse
A new test could improve care for patients with stomach or oesophageal cancer by predicting their likelihood of relapse after chemotherapy and surgery.
Weight loss drug could help treat advanced ovarian cancer
A weight loss drug available over the counter in the UK could help women with treatment-resistant ovarian cancer respond to chemotherapy again, a new study suggests.
Scientists uncover why testicular cancer runs in families
Testicular cancer in families is usually caused by the accumulation of minor genetic changes that have only a small effect on their own, but together can add up to a significant risk.
Targeting inflammation could help treat drug-resistant bowel cancer
Some bowel cancers that are resistant to treatment could be re-sensitised using drugs that reduce inflammation, according to new research.
Call for hospitals to use high-tech scans to diagnose prostate cancers when they can still be cured
Modern, sophisticated scans should be used in hospitals to pick out men whose prostate cancers have only spread to a limited number of sites, so they can be offered the chance of cure, a new assessment concludes.
How our supporters are helping us take on ‘stealth’ cancers
Professor Raj Chopra, Head of Cancer Therapeutics, thanked ICR supporters and spoke about his hopes for the future for cancer treatment – made possible by their support.
Patients with HPV-positive throat cancer should keep taking chemotherapy
Patients with human papillomavirus (HPV)-positive throat cancer should carry on receiving chemotherapy rather than switching to a targeted cancer drug, new clinical trial results have shown.
Public-private sector collaboration the theme as Minister visits The London Cancer Hub
Business Minister Lord Henley has visited The London Cancer Hub to discuss new opportunities for life-sciences businesses to collaborate with world-leading scientists from The Institute of Cancer Research (ICR), London.
